Trademark Overview
On Tuesday, August 25, 2020, a trademark application was filed for ADJUVANCE with the United States Patent and Trademark Office. The USPTO has given the ADJUVANCE trademark a serial number of 90135205. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, July 6, 2021. This trademark is owned by Adjuvance Technologies, Inc.. The ADJUVANCE trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Medical, biological, pharmaceutical, and biopharmaceutical preparations and substances for scientific, research, medical, or pharmaceutical use, namely, preparations and substances for treating cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious diseases and disorders, autoimmune disorders, and reproductive disorders; medical diagnostic reagents; vaccines
Medical, biological, pharmaceutical, and biopharmaceutical preparations and substances for scientific, research, medical, or pharmaceutical use, namely, preparations and substances for treating cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious diseases and disorders, autoimmune disorders, and reproductive disorders; medical diagnostic reagents; vaccines
Scientific research; pharmaceutical, biologic, and vaccine research and development; providing medical and scientific research information in the field of pharmaceuticals, biologics, biotherapies, therapeutics, and vaccines